As shown in Figures 1A–D, a qPCR analysis of the gene expression of RAS components revealed a marked down-regulation of ACE and AT1R, as well as an upregulation of ACE2 and Mas mRNA levels in the hepatic tissues of the liraglutide group compared with the NAFLD mice. This evidence concerns the gene ACE and metabolic dysfunction-associated steatotic liver disease.